Deformulation of oral solid dose (OSD) products requires generic companies to determine the physical and chemical properties of the excipients and active pharmaceutical ingredients (APIs) present within the reference listed drug product (RLD). In this webinar, we introduce a workflow for OSD deformulation and explore how Morphologically Directed Raman Spectroscopy can aid formulation developers in understanding the properties and possible manufacturing methods applied in development of an innovator product.